Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy. | NAR Cancer | 2022 | 35252867 | PubTator, text mining | PubMed |
| Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease). | Front Cell Dev Biol | 2022 | 35252181 | PubTator, text mining | PubMed |
| The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review. | Front Pharmacol | 2022 | 35250554 | PubTator, text mining | PubMed |
| Indoxyl sulfate- and P-cresol-induced monocyte adhesion and migration is mediated by integrin-linked kinase-dependent podosome formation. | Exp Mol Med | 2022 | 35246616 | PubTator, text mining | PubMed |
| Novel Role of Prereplication Complex Component Cell Division Cycle 6 in Retinal Neovascularization. | Arterioscler Thromb Vasc Biol | 2022 | 35236105 | PubTator, text mining | PubMed |
| FAIMS Enhances the Detection of PTM Crosstalk Sites. | J Proteome Res | 2022 | 35235327 | PubTator, text mining | PubMed |
| Heterozygous FMN2 missense variant found in a family case of premature ovarian insufficiency. | J Ovarian Res | 2022 | 35227295 | PubTator, text mining | PubMed |
| Podocyte Endocytosis in Regulating the Glomerular Filtration Barrier. | Front Med (Lausanne) | 2022 | 35223901 | PubTator, text mining | PubMed |
| Unbiased proteomic profiling reveals the IP3R modulator AHCYL1/IRBIT as a novel interactor of microtubule-associated protein tau. | J Biol Chem | 2022 | 35218773 | PubTator, text mining | PubMed |
| Unconventional protein post-translational modifications: the helmsmen in breast cancer. | Cell Biosci | 2022 | 35216622 | PubTator, text mining | PubMed |
| Engineering Chimeras by Fusing Plant Receptor-like Kinase EMS1 and BRI1 Reveals the Two Receptors' Structural Specificity and Molecular Mechanisms. | Int J Mol Sci | 2022 | 35216268 | PubTator, text mining | PubMed |
| Actin-Associated Proteins and Small Molecules Targeting the Actin Cytoskeleton. | Int J Mol Sci | 2022 | 35216237 | PubTator, text mining | PubMed |
| Noninvasive Systemic Modalities for Prevention of Head and Neck Radiation-Associated Soft Tissue Injury: A Narrative Review. | J Reconstr Microsurg | 2022 | 35213927 | PubTator, text mining | PubMed |
| Molecular neuropathology of brain-invasive meningiomas. | Brain Pathol | 2022 | 35213084 | PubTator, text mining | PubMed |
| Flurbiprofen inhibits cell proliferation in thyroid cancer through interrupting HIP1R-induced endocytosis of PTEN. | Eur J Med Res | 2022 | 35209947 | PubTator, text mining | PubMed |
| Development of Gene Expression-Based Random Forest Model for Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 35205629 | PubTator, text mining | PubMed |
| Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives. | Biomolecules | 2022 | 35204811 | PubTator, text mining | PubMed |
| piRNAs and PIWI Proteins as Diagnostic and Prognostic Markers of Genitourinary Cancers. | Biomolecules | 2022 | 35204687 | PubTator, text mining | PubMed |
| Targeted NMDA Receptor Interventions for Autism: Developmentally Determined Expression of GluN2B and GluN2A-Containing Receptors and Balanced Allosteric Modulatory Approaches. | Biomolecules | 2022 | 35204682 | PubTator, text mining | PubMed |
| Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours. | Cells | 2022 | 35203300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=39